EP2982985A4 - System zur vorhersage einer prognose von lokal fortgeschrittenem magenkrebs - Google Patents
System zur vorhersage einer prognose von lokal fortgeschrittenem magenkrebsInfo
- Publication number
- EP2982985A4 EP2982985A4 EP14779566.0A EP14779566A EP2982985A4 EP 2982985 A4 EP2982985 A4 EP 2982985A4 EP 14779566 A EP14779566 A EP 14779566A EP 2982985 A4 EP2982985 A4 EP 2982985A4
- Authority
- EP
- European Patent Office
- Prior art keywords
- gastric cancer
- locally advanced
- predicting prognosis
- advanced gastric
- prognosis
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 208000005718 Stomach Neoplasms Diseases 0.000 title 1
- 206010017758 gastric cancer Diseases 0.000 title 1
- 238000004393 prognosis Methods 0.000 title 1
- 201000011549 stomach cancer Diseases 0.000 title 1
Classifications
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
- G16B25/00—ICT specially adapted for hybridisation; ICT specially adapted for gene or protein expression
- G16B25/10—Gene or protein expression profiling; Expression-ratio estimation or normalisation
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6813—Hybridisation assays
- C12Q1/6834—Enzymatic or biochemical coupling of nucleic acids to a solid phase
- C12Q1/6837—Enzymatic or biochemical coupling of nucleic acids to a solid phase using probe arrays or probe chips
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
- C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/5308—Immunoassay; Biospecific binding assay; Materials therefor for analytes not provided for elsewhere, e.g. nucleic acids, uric acid, worms, mites
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
- G01N33/57407—Specifically defined cancers
- G01N33/57446—Specifically defined cancers of stomach or intestine
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
- G16B25/00—ICT specially adapted for hybridisation; ICT specially adapted for gene or protein expression
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2537/00—Reactions characterised by the reaction format or use of a specific feature
- C12Q2537/10—Reactions characterised by the reaction format or use of a specific feature the purpose or use of
- C12Q2537/165—Mathematical modelling, e.g. logarithm, ratio
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/118—Prognosis of disease development
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/158—Expression markers
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Physics & Mathematics (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Immunology (AREA)
- General Health & Medical Sciences (AREA)
- Biotechnology (AREA)
- Organic Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biophysics (AREA)
- Analytical Chemistry (AREA)
- Wood Science & Technology (AREA)
- Pathology (AREA)
- Zoology (AREA)
- Microbiology (AREA)
- Biochemistry (AREA)
- Theoretical Computer Science (AREA)
- Spectroscopy & Molecular Physics (AREA)
- Medical Informatics (AREA)
- Evolutionary Biology (AREA)
- Bioinformatics & Computational Biology (AREA)
- Urology & Nephrology (AREA)
- Hematology (AREA)
- Biomedical Technology (AREA)
- General Engineering & Computer Science (AREA)
- Hospice & Palliative Care (AREA)
- Oncology (AREA)
- Cell Biology (AREA)
- General Physics & Mathematics (AREA)
- Medicinal Chemistry (AREA)
- Food Science & Technology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Apparatus Associated With Microorganisms And Enzymes (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020130037334A KR101504817B1 (ko) | 2013-04-05 | 2013-04-05 | 국소 진행형 위암에 대한 예후 예측 시스템 |
PCT/KR2014/002958 WO2014163444A1 (ko) | 2013-04-05 | 2014-04-07 | 국소 진행형 위암에 대한 예후 예측 시스템 |
Publications (3)
Publication Number | Publication Date |
---|---|
EP2982985A1 EP2982985A1 (de) | 2016-02-10 |
EP2982985A4 true EP2982985A4 (de) | 2016-11-09 |
EP2982985B1 EP2982985B1 (de) | 2018-09-05 |
Family
ID=51658660
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP14779566.0A Active EP2982985B1 (de) | 2013-04-05 | 2014-04-07 | System zur vorhersage einer prognose von lokal fortgeschrittenem magenkrebs |
Country Status (6)
Country | Link |
---|---|
US (1) | US20160063179A1 (de) |
EP (1) | EP2982985B1 (de) |
JP (1) | JP6280206B2 (de) |
KR (1) | KR101504817B1 (de) |
CN (1) | CN105431737B (de) |
WO (1) | WO2014163444A1 (de) |
Families Citing this family (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2016181979A1 (ja) * | 2015-05-13 | 2016-11-17 | 国立大学法人名古屋大学 | Syt7・mfsd4・etnk2発現量による胃癌肝転移の検査方法、検査キット、分子標的治療薬スクリーニング方法、医薬組成物 |
CN105986034A (zh) * | 2016-06-15 | 2016-10-05 | 南京卡迪睿伯生物技术有限公司 | 一组胃癌基因的应用 |
CN106874647B (zh) * | 2017-01-06 | 2019-03-22 | 吴安华 | 一种脑胶质母细胞瘤患者生存期预测系统 |
CA3055735C (en) | 2017-03-14 | 2021-12-14 | Novomics Co., Ltd. | System for predicting prognosis and benefit from adjuvant chemotherapy for patients with stage ii and iii gastric cancer |
CN106841619A (zh) * | 2017-03-17 | 2017-06-13 | 中国科学院上海高等研究院 | 三种蛋白质用作鉴定淋巴结转移胃癌的分子标记的应用 |
US11195601B2 (en) | 2017-05-31 | 2021-12-07 | International Business Machines Corporation | Constructing prediction targets from a clinically-defined hierarchy |
EP3891761A4 (de) * | 2018-12-06 | 2022-06-15 | B.G. Negev Technologies and Applications Ltd., at Ben-Gurion University | Integriertes system und verfahren zur personalisierten stratifizierung und vorhersage einer neurodegenerativen erkrankung |
CN109652548B (zh) * | 2019-01-21 | 2022-08-05 | 首都医科大学附属北京朝阳医院 | circ-CCNB1作为胃癌和结直肠癌诊断生物标志物和治疗靶点的应用 |
US20230132750A1 (en) * | 2020-04-08 | 2023-05-04 | Gencurix Inc. | Composition for diagnosing colorectal cancer, rectal cancer, or colorectal adenoma using cpg methylation change of glrb gene, and use thereof |
CN113053456B (zh) * | 2021-03-23 | 2023-04-04 | 广州医科大学附属第二医院 | Aml患者免疫分型系统、aml患者预后评分模型及其构建方法 |
KR20220148615A (ko) * | 2021-04-29 | 2022-11-07 | 연세대학교 산학협력단 | 위암의 예후 예측 방법 |
CN113462773A (zh) * | 2021-05-19 | 2021-10-01 | 山东大学 | 一种预测胃癌患者生存风险、免疫治疗响应和细胞焦亡诱导剂适用性的标志物及其应用 |
KR20230067551A (ko) * | 2021-11-09 | 2023-05-16 | 연세대학교 산학협력단 | 난치성 분자아형 암 치료 표적으로서 고atp친화성 단백질 및 이의 억제제 |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2008063521A2 (en) * | 2006-11-13 | 2008-05-29 | The General Hospital Corporation | Gene-based clinical scoring system |
WO2009045115A1 (en) * | 2007-10-05 | 2009-04-09 | Pacific Edge Biotechnology Ltd | Proliferation signature and prognosis for gastrointestinal cancer |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1333278B1 (de) * | 2002-02-01 | 2004-03-10 | MTM molecular tools in medicine | Verfahren zur Prognose gastrointestinaler Tumoren |
WO2005001126A1 (en) * | 2003-06-12 | 2005-01-06 | Korea Research Institute Of Bioscience And Biotechnology | Detection kit for gastric cancer and metastatic gastric cancer |
US20080275652A1 (en) * | 2005-05-13 | 2008-11-06 | Universite Libre De Bruxelles | Gene-based algorithmic cancer prognosis |
CN1973778A (zh) * | 2006-12-08 | 2007-06-06 | 南京大学 | 胃癌术后严重并发症风险度的预测方法 |
EP2358912B1 (de) * | 2008-10-30 | 2016-10-12 | Caris Life Sciences Switzerland Holdings GmbH | Verfahren zur untersuchung von rna-mustern |
JP2012508577A (ja) * | 2008-11-12 | 2012-04-12 | カリス ライフ サイエンシズ ルクセンブルク ホールディングス | 表現型を決定するためのエキソソームの使用方法およびそのシステム |
JPWO2010064702A1 (ja) * | 2008-12-05 | 2012-05-10 | 国立大学法人 東京大学 | 癌の予後を予測するためのバイオマーカー |
ES2689958T3 (es) * | 2010-12-13 | 2018-11-16 | Samsung Life Public Welfare Foundation | Marcador para predecir el pronóstico de cáncer de estómago y procedimiento para predecir el pronóstico de cáncer de estómago |
-
2013
- 2013-04-05 KR KR1020130037334A patent/KR101504817B1/ko active IP Right Grant
-
2014
- 2014-04-07 US US14/782,515 patent/US20160063179A1/en not_active Abandoned
- 2014-04-07 JP JP2016506252A patent/JP6280206B2/ja active Active
- 2014-04-07 CN CN201480024658.4A patent/CN105431737B/zh active Active
- 2014-04-07 EP EP14779566.0A patent/EP2982985B1/de active Active
- 2014-04-07 WO PCT/KR2014/002958 patent/WO2014163444A1/ko active Application Filing
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2008063521A2 (en) * | 2006-11-13 | 2008-05-29 | The General Hospital Corporation | Gene-based clinical scoring system |
WO2009045115A1 (en) * | 2007-10-05 | 2009-04-09 | Pacific Edge Biotechnology Ltd | Proliferation signature and prognosis for gastrointestinal cancer |
Non-Patent Citations (7)
Title |
---|
GUAN ZHEN YU ET AL: "Overexpression of Grb2/HER2 signaling in Chinese gastric cancer: their relationship with clinicopathological parameters and prognostic significance", JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, SPRINGER, BERLIN, DE, vol. 135, no. 10, 1 April 2009 (2009-04-01), pages 1331 - 1339, XP019740678, ISSN: 1432-1335, DOI: 10.1007/S00432-009-0574-8 * |
HIROSHI INOUE ET AL: "Prognostic Score of Gastric Cancer Determined by cDNA Microarray 1", CLINICAL CANCER RESEARCH, vol. 8, 1 November 2002 (2002-11-01), pages 3475 - 3479, XP055307731 * |
J. Y. CHO ET AL: "Gene Expression Signature-Based Prognostic Risk Score in Gastric Cancer", CLINICAL CANCER RESEARCH, vol. 17, no. 7, 29 March 2011 (2011-03-29), US, pages 1850 - 1857, XP055307553, ISSN: 1078-0432, DOI: 10.1158/1078-0432.CCR-10-2180 * |
K. E. LEE ET AL: "Prognostic Significance of p53, nm23, PCNA and c-erbB-2 in Gastric Cancer", JAPANESE JOURNAL OF CLINICAL ONCOLOGY, vol. 33, no. 4, 1 April 2003 (2003-04-01), pages 173 - 179, XP055307806, DOI: 10.1093/jjco/hyg039 * |
M YU SHABELNIK ET AL: "Differential expression of PKD1 and PKD2 in gastric cancer and analysis of PKD1 and PKD2 function in the model system", EXPERIMENTAL ONCOLOGY, 1 December 2011 (2011-12-01), Ukraine, pages 206 - 211, XP055307797, Retrieved from the Internet <URL:http://www.nbuv.gov.ua/old_jrn/Chem_Biol/eol/2011_4/206.pdf> * |
MASAKI MORI: "Clinicopathological and biological significance of CDC28 protein kinase regulatory subunit 2 overexpression in human gastric cancer", INTERNATIONAL JOURNAL OF ONCOLOGY, 25 May 2011 (2011-05-25), GR, XP055307799, ISSN: 1019-6439, DOI: 10.3892/ijo.2011.1056 * |
See also references of WO2014163444A1 * |
Also Published As
Publication number | Publication date |
---|---|
KR101504817B1 (ko) | 2015-03-24 |
WO2014163444A1 (ko) | 2014-10-09 |
EP2982985B1 (de) | 2018-09-05 |
JP6280206B2 (ja) | 2018-02-14 |
JP2016516421A (ja) | 2016-06-09 |
US20160063179A1 (en) | 2016-03-03 |
KR20140121522A (ko) | 2014-10-16 |
EP2982985A1 (de) | 2016-02-10 |
CN105431737B (zh) | 2017-11-24 |
CN105431737A (zh) | 2016-03-23 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP2982985A4 (de) | System zur vorhersage einer prognose von lokal fortgeschrittenem magenkrebs | |
IL276488A (en) | A method for predicting the prognosis of breast cancer | |
HK1217219A1 (zh) | 結直腸癌生物標誌物 | |
HK1219763A1 (zh) | 用於癌症預後的組合物和方法 | |
IL276505B (en) | Determination of recurrence of breast cancer | |
SG11201510210XA (en) | Methods for detecting prostate cancer | |
EP2986326A4 (de) | Verfahren zum nachweis von krebsmetastasen | |
EP2982986A4 (de) | Verfahren zur herstellung eines modells zur prognose von magenkrebs | |
HK1213634A1 (zh) | 檢測癌症的方法 | |
EP2985605A4 (de) | Verfahren zum nachweis von darmkrebs | |
SG11201602019XA (en) | Multigene assay for prognosis of renal cancer | |
HK1216779A1 (zh) | 用於癌症治療的預測性生物標記物 | |
EP2998740A4 (de) | Verfahren zur vorhersage der klinischen wirkung einer immuntherapie | |
IL227419A0 (en) | Symptomatic signature for colon cancer recurrence | |
HK1224010A1 (zh) | 卵巢癌生物標誌物 | |
EP3058101A4 (de) | Serum-mirnas zur prognose von prostatakrebs | |
EP3036712A4 (de) | Verfahren zur vorhersage einer prognose | |
EP2972376A4 (de) | Verfahren zur bestimmung der prognose von kolorektalkarzinom | |
GB201306339D0 (en) | Biomarkers for prognosis | |
EP3060914A4 (de) | Verfahren zur bestimmung einer brustkrebsprognose | |
SG11201608328RA (en) | Method for predicting response to therapy for cancer | |
HK1177502A1 (en) | Biomarker for gastric cancer | |
EP2997378A4 (de) | Verfahren zur bestimmung der prognose von krebs | |
GB201319237D0 (en) | Method for assessing the prognosis of a patient suffering from colorectal cancer | |
EP3077812A4 (de) | Verfahren zur prognose von brustkrebs |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
17P | Request for examination filed |
Effective date: 20151105 |
|
AK | Designated contracting states |
Kind code of ref document: A1 Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR |
|
AX | Request for extension of the european patent |
Extension state: BA ME |
|
DAX | Request for extension of the european patent (deleted) | ||
A4 | Supplementary search report drawn up and despatched |
Effective date: 20161012 |
|
RIC1 | Information provided on ipc code assigned before grant |
Ipc: G01N 33/574 20060101AFI20161006BHEP Ipc: G01N 33/53 20060101ALI20161006BHEP Ipc: C12Q 1/68 20060101ALI20161006BHEP |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: EXAMINATION IS IN PROGRESS |
|
17Q | First examination report despatched |
Effective date: 20170918 |
|
RAP1 | Party data changed (applicant data changed or rights of an application transferred) |
Owner name: NOVOMICS CO., LTD. |
|
REG | Reference to a national code |
Ref country code: DE Ref legal event code: R079 Ref document number: 602014031864 Country of ref document: DE Free format text: PREVIOUS MAIN CLASS: G01N0033574000 Ipc: C12Q0001688600 |
|
GRAP | Despatch of communication of intention to grant a patent |
Free format text: ORIGINAL CODE: EPIDOSNIGR1 |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: GRANT OF PATENT IS INTENDED |
|
RIC1 | Information provided on ipc code assigned before grant |
Ipc: C12Q 1/6886 20180101AFI20180523BHEP |
|
INTG | Intention to grant announced |
Effective date: 20180606 |
|
GRAS | Grant fee paid |
Free format text: ORIGINAL CODE: EPIDOSNIGR3 |
|
GRAA | (expected) grant |
Free format text: ORIGINAL CODE: 0009210 |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE PATENT HAS BEEN GRANTED |
|
AK | Designated contracting states |
Kind code of ref document: B1 Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR |
|
REG | Reference to a national code |
Ref country code: GB Ref legal event code: FG4D |
|
REG | Reference to a national code |
Ref country code: CH Ref legal event code: EP |
|
REG | Reference to a national code |
Ref country code: AT Ref legal event code: REF Ref document number: 1037867 Country of ref document: AT Kind code of ref document: T Effective date: 20180915 |
|
REG | Reference to a national code |
Ref country code: IE Ref legal event code: FG4D |
|
REG | Reference to a national code |
Ref country code: DE Ref legal event code: R096 Ref document number: 602014031864 Country of ref document: DE |
|
REG | Reference to a national code |
Ref country code: NL Ref legal event code: MP Effective date: 20180905 |
|
REG | Reference to a national code |
Ref country code: LT Ref legal event code: MG4D |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: FI Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20180905 Ref country code: SE Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20180905 Ref country code: BG Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20181205 Ref country code: GR Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20181206 Ref country code: LT Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20180905 Ref country code: NO Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20181205 Ref country code: RS Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20180905 |
|
REG | Reference to a national code |
Ref country code: AT Ref legal event code: MK05 Ref document number: 1037867 Country of ref document: AT Kind code of ref document: T Effective date: 20180905 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: HR Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20180905 Ref country code: AL Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20180905 Ref country code: LV Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20180905 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: ES Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20180905 Ref country code: IS Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20190105 Ref country code: AT Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20180905 Ref country code: EE Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20180905 Ref country code: NL Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20180905 Ref country code: CZ Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20180905 Ref country code: RO Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20180905 Ref country code: PL Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20180905 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: SM Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20180905 Ref country code: PT Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20190105 Ref country code: SK Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20180905 |
|
REG | Reference to a national code |
Ref country code: DE Ref legal event code: R097 Ref document number: 602014031864 Country of ref document: DE |
|
PLBE | No opposition filed within time limit |
Free format text: ORIGINAL CODE: 0009261 |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: NO OPPOSITION FILED WITHIN TIME LIMIT |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: DK Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20180905 |
|
26N | No opposition filed |
Effective date: 20190606 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: SI Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20180905 |
|
REG | Reference to a national code |
Ref country code: CH Ref legal event code: PL |
|
REG | Reference to a national code |
Ref country code: BE Ref legal event code: MM Effective date: 20190430 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: LU Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20190407 Ref country code: MC Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20180905 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: LI Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20190430 Ref country code: CH Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20190430 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: BE Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20190430 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: TR Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20180905 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: IE Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20190407 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: CY Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20180905 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: HU Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT; INVALID AB INITIO Effective date: 20140407 Ref country code: MT Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20180905 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: MK Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20180905 |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: IT Payment date: 20230426 Year of fee payment: 10 Ref country code: FR Payment date: 20230424 Year of fee payment: 10 |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: GB Payment date: 20240419 Year of fee payment: 11 |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: DE Payment date: 20240418 Year of fee payment: 11 |